Viewing StudyNCT02918318



Ignite Creation Date: 2024-05-06 @ 9:09 AM
Last Modification Date: 2024-10-26 @ 12:10 PM
Study NCT ID: NCT02918318
Status: COMPLETED
Last Update Posted: 2020-10-19
First Post: 2016-09-27

Brief Title: A Study to Evaluate the Efficacy Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression
Sponsor: Janssen Pharmaceutical KK
Organization: Janssen Pharmaceutical KK

Organization Data

Organization: Janssen Pharmaceutical KK
Class: INDUSTRY
Study ID: CR108227
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Janssen Pharmaceutical KK
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators